Wanted: Drugs to Fight Bioterror
“Amid new warnings about a possible summer of terror, the U.S. government is preparing to spend billons to coax pharmaceutical companies to develop drugs to fend off a biological or chemical attack. But experts say the infusion of cash may be little more than a good start.”
Eco-Terror Cited as Top Threat
Law enforcement officials warn that biotechnology firms, particularly
those that conduct research on animals, must take greater precautions
against attacks by extremist groups.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments